Stroke is the third leading cause of death in the United States after heart disease and cancer, with an incidence of 750'000 per year.

Ischemic Stroke

Annually, 15 million people worldwide suffer from stroke. 5.5 million of them die and another 5 million are left permanently disabled. In China (1/5th of the world population) the incidence of stroke is even 5 to 10 times higher.

➢ NeMo Patch allows for decisions for reperfusion therapies like i.e. thrombolysis after acute ischemic stroke especially in comatose and sedated patients.

Head trauma

In Switzerland 1'000 – 1'500, in the USA 250'000 patients per year suffer from severe head injury and require probes for ICP-monitoring.

➢ NeMo Probe and NeMo Patch allow for for specific management of the exact needs of each individual brain injured patient.

A paradigm shift from pulse oximetry using the signal taken from the finger tip and earlobe to NIRS oximetry using the signal obtained from the brain (the recent most vital for surviving without brain damage and a good quality of life) has to be targeted and educated in the future.

Therefore, all patients with imminent oxygen deficiency qualify for the NeMo Patch. According to the latest WHO estimates (2007), currently 300 million people have asthma and 210 million people have chronic obstructive pulmonary disease.

➢ NeMo Patch has the potential to become a precious modular extension in all conventional monitoring systems applied in emergency departments, intensive care and operation units.